| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Holstein Jens serves as a Director at VCYT. Across recent SEC filings that breaks down to 1 buy and 9 sells. Those positions are worth an estimated $1.1M at current prices.
Historically, Holstein Jens's trades have earned a below-average insider score of 36/100 across 5 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -28.3%.
The biggest single holding is VCYT (~$1.1M) as Director. The recent filings there lean toward selling, a net 31,720 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | VCYT Veracyte, Inc. | Director | Sell | 5,000 | $40.95 | $204,747.00 | -15.4% | - | - | |
| Nov 20, 2025 | VCYT Veracyte, Inc. | Director | Sell | 10,000 | $42.36 | $423,563.05 | -26.9% | -10.4% | - | |
| Aug 7, 2024 | VCYT Veracyte, Inc. | Director | Sell | 5,000 | $29.00 | $145,000.00 | -15.2% | +32.8% | +2.3% | |
| Jul 16, 2024 | VCYT Veracyte, Inc. | Director | Sell | 5,000 | $24.50 | $122,500.00 | -13.2% | +32.7% | -1.5% | |
| Jun 14, 2022 | VCYT Veracyte, Inc. | Director | Sell | 8,720 | $16.27 | $141,846.50 | -81.3% | +28.9% | +63.0% | |
| Jun 3, 2021 | VCYT Veracyte, Inc. | Director | Buy | 2,000 | $35.19 | $70,389.20 | New | +52.3% | -49.5% |